Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02756754 | Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism(ADERADHTA) | completed | N/A | 31 | University Hospital, ToulouseOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06576336 | A Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery(3DAdrenal) | completed | Phase 4 | 350 | University of PalermoOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT06050057 | Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy | unknown | — | 100 | University Hospital OlomoucOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT05991856 |
Data updated 22 days agoSource updated May 4, 2026source: clinicaltrials
| Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma |
| recruiting |
| — |
| 45 |
| Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER |
| 1 |
| Aug 15, 2023 |
| clinicaltrials |
| NCT04890444 | China Adrenal Disease Registry(CASE) | unknown | — | 2,000 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02468193 | Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome | completed | Phase 2 | 9 | Novartis PharmaceuticalsINDUSTRY | 1 | May 6, 2020 | clinicaltrials |
| NCT03474237 | A Prospective Cohort Study for Patients With Adrenal Diseases | enrolling by invitation | — | 1,500 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03830593 | Laparoscopic Adrenalectomy for Large Adrenal Tumors. | completed | — | 102 | Samsun Liv HospitalOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT02030587 | Laparoscopic Adrenalectomy Versus Radiofrequency Ablation(LARFA) | unknown | N/A | 36 | Chinese University of Hong KongOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |